Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine sedation for pediatric intra-articular joint injections
2016-002065-66Phase 4Completed
- Sponsor
- Miikka Tervonen
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in arthritis (2 arms), sponsored by Miikka Tervonen. Primary endpoint: Pain during procedure. Started Nov 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
arthritis
Beyond the preview
Go deeper on 2016-002065-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002065-66.